The Rise of Healthtech: A Prime Opportunity for Private Equity
As healthcare systems evolve under mounting pressure for efficiency, personalization, and digital integration, Healthtech is emerging as one of the most investable frontiers in the global economy.
Record investment is flooding renewables, but the hardest problems—CCS, hydrogen, clean shipping—still need risk-tolerant capital. That’s where PE comes in.
It's Wednesday, and we're covering private equity’s dealmaking in mid-market healthcare, share of TTM capital raised in private equity, private credit growth in emerging markets and the structural long-term problem of US trade balance.
Private Equity Dealmaking Rebounds, But Selectively
PE deal value hit $93B in Q1 2025, but volume remains tight. Discover how sponsors are prioritizing pricing power, exit liquidity, and strategic sectors.
